Novavax
Novavax, Inc., is an American biotechnology company based in Gaithersburg, Maryland that creates vaccines to fight against serious infectious diseases. Before to 2020, company scientists developed experimental vaccines for Ebola, influenza, respiratory syncytial virus (RSV), and other emerging infectious diseases.
During 2020, however, the company redirected its efforts to focus on development and approval of a vaccine for COVID-19.[1]
Novavax Media
Novavax CEO and President Stanley Erck, in conference during Governor Larry Hogan's visit to Novavax Laboratories in Gaithersburg, Maryland, in September 2020
Novavax research and development laboratories in Gaithersburg.
Stanley Erck (right) and Gregory Glenn (left) at the biotech labs in Gaithersburg during the visit of the Governor of Maryland in September 2020
Governor Larry Hogan at Novavax's future Vaccines Innovation Campus and global headquarters in Maryland.
.jpg)
References
- ↑ Novavax Inc. 2020 Annual Report Archived 2021-08-14 at the Wayback Machine. Accessed 10 May 2021.
This short article about the United States can be made longer. You can help Wikipedia by adding to it.